In a bid to preserve its Lipitor market share in coming months, Pfizer has offered an unprecedented deal to the nation's largest prescription benefit managers. They can purchase Lipitor at below cost for the next 6 months. The catch? Companies...
Continue reading this article, and get more corporate counsel news and information, at FindLaw.com.